News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
GenoMed, Inc. Welcomes Dame Shirley Bassey as Its First Patron
June 12, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ST. LOUIS—June 12, 2007--GenoMed (OTC Pink Sheets GMED), a Next Generation Disease Management company whose business is public health™, today announced that Dame Shirley Bassey has agreed to become the company’s first Patron.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Cancer
Boehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenics
September 22, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
BMS says goodbye to 265 New Jersey staff as reorg rolls on
September 22, 2026
·
95 min read
·
BioSpace Editorial Staff
Manufacturing
Western licensing deals for Chinese radioligand therapies to jump in 2027, Sleuth forecasts
September 21, 2026
·
2 min read
·
Nick Paul Taylor
C-suite
Novo’s plan to hit $23B in revenue by 2035 leaves investors wanting
September 21, 2026
·
5 min read
·
Annalee Armstrong
